Bayer Launches Campaign to Promote Science and Combat Misinformation

Bayer Launches “Science Delivers” Campaign to Combat Misinformation on World Science Day

Bayer has unveiled a new public campaign celebrating scientific research and advancement to coincide with World Science Day. The “Science Delivers” initiative aims to help scientists, educators, media professionals, and the general public identify misinformation and counter pseudoscience in an increasingly polarized environment.

The pharmaceutical and biotechnology giant’s campaign comes at a critical time when conflicting ideologies are penetrating scientific discourse, and American scientific research faces threats of funding cuts and government layoffs.

“As a science-based company, science is at the heart of everything we do – whether it’s developing new tools and technologies for farmers, patients or everyday consumers,” said Jess Christiansen, Bayer’s head of sustainability and crop science communications. “Today, on National Science Day, is the perfect time to launch a campaign that recognizes the important role that science plays in our lives, celebrate its impact and challenge misinformation.”

The comprehensive campaign features an interactive website, nationally broadcast video advertisements, and oversized “Science, Sealed, Delivered” mailboxes deployed at select events and locations. Most recently, these mailboxes appeared at the World Food Prize’s 2025 Borlaug Dialogue in Des Moines, Iowa, one of the world’s premier gatherings for global agriculture and food security discussions.

These mailboxes serve as collection points for public stories about science’s positive impact. Each installation includes a QR code allowing visitors to submit digital postcards sharing how science has sparked change, inspired hope, or initiated progress in their lives and communities. These testimonials will be showcased on the campaign’s dedicated website.

As part of this initiative, Bayer is publishing a “Declaration on Science” in major publications including the Wall Street Journal, the Washington Times, and Politico. The declaration emphasizes the importance of innovation in creating a healthier, more sustainable society, stating: “We must strive to be healthier, more sustainable, and focused on what innovation can bring to improve society. We must celebrate science and continue every day to innovate. To find the next cure. To find the next breakthrough.”

The campaign’s timing aligns with a broader trend across industries, particularly in the wellness sector, where companies are increasingly partnering with scientific experts to establish credibility and strengthen science-backed branding. Brands like Next Health, Bon Charge, Therabody, SWTHZ, and Ammortal have recently appointed medical doctors and other scientific professionals to leadership positions or scientific advisory boards to oversee product development and research initiatives.

Bayer’s emphasis on science comes at a particularly challenging moment for scientific discourse. Public trust in scientific institutions has been eroded in recent years, with political polarization affecting how research findings are perceived and communicated. The COVID-19 pandemic highlighted this divide, as public health recommendations became politicized and misinformation spread rapidly through social media platforms.

For Bayer, a company with significant stakes in both pharmaceutical development and agricultural technology, championing science isn’t just a public relations exercise but a core business interest. The company’s diverse portfolio includes medications, consumer health products, and crop science solutions—all areas where public understanding and acceptance of science directly impact market performance.

Industry analysts suggest that campaigns like “Science Delivers” represent a growing recognition among science-based corporations that they must take a more active role in public science communication and education. With declining trust in traditional institutions, companies like Bayer are stepping in to advocate for evidence-based decision making and scientific literacy.

The initiative also comes as Bayer navigates various challenges, including ongoing litigation related to its Roundup weedkiller and evolving regulatory landscapes across its business sectors. By positioning itself as a champion of scientific integrity, the company appears to be reinforcing its commitment to research-driven solutions while encouraging broader public engagement with science.